Adaptive Biotechnologies Corp
Change company Symbol lookup
Select an option...
ADPT Adaptive Biotechnologies Corp
TDOC Teladoc Health Inc
SPNE SeaSpine Holdings Corp
GBT Global Blood Therapeutics Inc
NYMT New York Mortgage Trust Inc
HY Hyster-Yale Materials Handling Inc
NTES NetEase Inc
EV Eaton Vance Corp
IPG Interpublic Group of Companies Inc
DDD 3D Systems Corp

Company profile

Adaptive Biotechnologies Corp is a biotechnology company. The Company is focused on using the biology of the adaptive immune system to develop the diagnosis and treatment of disease. Its immune medicine platform generates clinical immunomics data to decode the adaptive immune system. Its products and pipeline includes immunoSEQ, clonoSEQ and cellular therapy. It offers its immunoSEQ technology as a service and a kit. immunoSEQ utilizes bias-controlled polymerase chain reaction (PCR) to sequence immune receptors from deoxyribonucleic (DNA). clonoSEQ is its diagnostic test product for the detection and next-generation sequencing (NGS)-based monitoring of minimal residual disease (MRD) in bone marrow samples in patients with myeloma (MM) and acute lymphoblastic leukemia (ALL). clonoSEQ is designed to sequence all rearranged receptor sequences in a tumor in parallel to enable MRD monitoring. It also focuses on developing immune-mediated therapies in oncology and other disease areas.

Day's Change
0.20 (0.67%)
B/A Size
Day's High
Day's Low

Today's volume of 100,809 shares is on pace to be much lighter than ADPT's 10-day average volume of 855,038 shares.


UPDATE: Kraft Heinz investor bids for Thyssenkrupp's elevator business

8:59 am ET November 13, 2019 (MarketWatch)

By Lina Saigol

Private equity firm 3G Capital has entered the bidding for a majority stake in Thyssenkrupp's elevator business, which could be valued at up to $20 billion.

The move marks a radical shift in strategy for the Brazilian-backed buyout group, which is food and beverage company Kraft Heinz's (KHC) second largest investor and has been heavily focused on deals in the consumer goods industry.

It teamed up with Warren Buffet's Berkshire Hathaway conglomerate (BRKA) to merge Kraft Foods Group and H.J. Heinz in 2015. The two have also worked together to buy fast-food giant Burger King, the fried-chicken restaurant Popeyes (, and popular Canadian chain Tim Hortons.

However, 3G, which has around $10 billion of cash to spend on acquisitions, has been scouting for a new deal following the poor performance of Kraft Heinz ( The company has reported 13 quarters of weak sales amid changing consumer tastes that are shunning packaged foods in favor of fresh, natural and local alternatives.

The U.S. food group booked a $15 billion writedown on the value of Kraft in February and disclosed an investigation by the U.S. Securities and Exchange Commission into its accounting practices. In July, it appointed Miguel Patricio as its new chief executive to help turnaround the company. He is due to announce a strategic review of the business next year.

Thyssenkrupp (TKA.XE) has put its elevator division on the block as the steel-to-submarine conglomerate ( to raise cash and reduce debt amid the weakening German economy. The company named Martina Mertz as its new chief executive in September.

3G will face tough competition from several other bidders, including a buyout consortium comprising Advent, Cinven and the Abu Dhabi Investment Authority.

It will compete with a rival consortium made up of Blackstone, Carlyle and the Canada Pension Plan Investment Board, while Finland's engineering company Kone is expected to team up with private equity group CVC to bid for the business.

3G's interest in ThyssenKrupp's elevator unit was first reported by Bloomberg on Tuesday.

-Lina Saigol; 415-439-6400;

(END) Dow Jones Newswires

November 13, 2019 08:59 ET (13:59 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.